Skip to main content Back to Top
Advertisement

8/27/2024

Cefazolin Injection

Products Affected - Description

    • Cefazolin injection, Baxter, 1 gram/50 mL, premixed bag, 24 count, NDC 00338-3503-41
    • Cefazolin injection, Baxter, 2 gram/100 mL, premixed bag, 12 count, NDC 00338-3508-41
    • Cefazolin powder for solution for injection, Sagent, 1 gram, vial, 25 count, NDC 25021-0101-10
    • Cefazolin powder for solution for injection, Sagent, 10 gram, vial, 1 count, NDC 25021-0102-99
    • Cefazolin powder for solution for injection, Sagent, 500 mg, vial, 25 count, NDC 25021-0100-10

Reason for the Shortage

    • Apotex has cefazolin injection available.
    • Baxter has cefazolin injection available.
    • BBraun has cefazolin injection available.
    • Fresenius Kabi has cefazolin injection available.
    • Hikma did not provide a reason for the shortage.
    • Pfizer has cefazolin injection available.
    • Sagent did not provide a reason for the shortage.
    • Samson Medical Technologies has cefazolin injection available.
    • Sandoz did not provide a reason for the shortage.
    • WG Critical Care has cefazolin injection available.

Available Products

    • Cefazolin powder for solution for injection, Apotex, 1 gram, vial, 25 count, NDC 60505-6142-05
    • Cefazolin powder for solution for injection, Apotex, 10 gram, vial, 10 count, NDC 60505-6143-04
    • Cefazolin powder for solution for injection, Apotex, 2 gram, vial, 25 count, NDC 60505-6231-05
    • Cefazolin injection, BBraun, 1 gram/50 mL, premixed bag, 1 count, NDC 00264-3103-11
    • Cefazolin injection, BBraun, 2 gram/50 mL, premixed bag, 1 count, NDC 00264-3105-11
    • Cefazolin powder for solution for injection, Fresenius Kabi, 1 gram, vial, 25 count, NDC 63323-0237-10
    • Cefazolin powder for solution for injection, Fresenius Kabi, 10 gram, vial, 1 count, NDC 63323-0238-61
    • Cefazolin powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0236-10
    • Cefazolin powder for solution for injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9924-90
    • Cefazolin powder for solution for injection, Hikma, 10 gram, vial, 10 count, NDC 00143-9983-03
    • Cefazolin powder for solution for injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9139-25
    • Cefazolin powder for solution for injection, Hikma, 3 gram, vial, 25 count, NDC 00143-9140-25
    • Cefazolin powder for solution for injection, Hikma, 500 mg, vial, 25 count, NDC 00143-9923-90
    • Cefazolin powder for solution for injection, Pfizer, 1 gram, ADD-Vantage vial, 25 count, NDC 00409-2585-01
    • Cefazolin powder for solution for injection, Samson Medical Technologies, 100 gram, SmartPak bag, 1 count, NDC 66288-1100-01
    • Cefazolin powder for solution for injection, Samson Medical Technologies, 300 gram, SmartPak bag, 1 count, NDC 66288-1300-01
    • Cefazolin powder for solution for injection, Sandoz, 1 gram, vial, 25 count, NDC 00781-3451-96
    • Cefazolin powder for solution for injection, Sandoz, 10 gram, vial, 10 count, NDC 00781-3452-95
    • Cefazolin powder for solution for injection, WG Critical Care, 1 gram, vial, 25 count, NDC 44567-0707-25
    • Cefazolin powder for solution for injection, WG Critical Care, 10 gram, vial, 10 count, NDC 44567-0708-10
    • Cefazolin powder for solution for injection, WG Critical Care, 2 gram, vial, 25 count, NDC 44567-0840-25
    • Cefazolin powder for solution for injection, WG Critical Care, 500 mg, vial, 25 count, NDC 44567-0706-25

Estimated Resupply Dates

    • Baxter has cefazolin 1 gram/50 mL premixed bags and 2 gram /100 mL premixed bags available for direct orders only.
    • Sagent has cefazolin 500 mg vials, 1 gram vials, and 10 gram on back order and the company cannot estimate a release date.

Updated

Updated August 27, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 5, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT